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1998) and for a quantitative phenotype (van den Oord
2000).
Furthermore, some of the assessments made by La-
buda et al. miss the mark. They assume (see their fig. 1)
that under scenario A, where the offspring genotype is
the one that “counts,” the parents of affected children
will resemble control parents with respect to the gene
under study. This ignores the fact that the genotypes of
parents and their children are correlated. Just as the par-
ents of offspring with Huntington disease will differ
from population controls in their prevalence of the allele
for Huntington disease, parents of offspring who have
a complex disease will tend to differ from population
controls. Thus, the case-control analyses reported in ta-
ble 1 of Labuda et al. (2002) are not specific to parentally
mediated genetic effects.
There are other reasons, biologic and technical, to
doubt the interpretation offered by Labuda et al., who
suggest that their data support a parent-mediated effect
of CYP2E1*5 on risk of childhood acute lymphoblastic
leukemia. First, the mechanisms by which the maternal
and paternal genotypes would influence offspring phe-
notype are very different (i.e., in utero environment vs.
DNA replication errors that produce genetically abnor-
mal sperm). It thus seems unlikely that the etiology of
a given condition would be related to both maternal and
paternal effects of a single gene. Rather, similar “effects”
of the maternal and paternal genotypes, on the basis of
case-control parental data, seem more likely due to the
selection of a biased control group or to offspring-me-
diated effects that have confounded the comparison of
the (correlated) parental genotypes. Thus, the data of-
fered by Labuda et al., which show very similar odds
ratios for the mother and for the father, may be seen
more plausibly as reflecting either a systematic bias in
the control group or a chance finding.
The final issue is analytic. The odds ratio parameter
estimated by the case-control analysis is not the same as
that estimated by transmissions. Labuda et al. evidently
used a standard method for paired data, calculating the
ratio of counts for discordant transmission pairs based
on heterozygous parents. This approach estimates the
relative penetrance for carriers of a single copy of the
variant allele under a gene dose model in which the
relative penetrance for two copies is the square of that
for one copy. By contrast, in their case-control analysis,
Labuda et al. use carrier status, which presumes a dom-
inant model. The paired estimator based on transmis-
sions can be shown to be biased toward 1.0 under such
a model. Even if the two analyses were estimating the
same parameter, there is considerable overlap in the CIs
for the two estimates. For these reasons, the results pre-
sented by Labuda et al. (2002) should be seen as pro-
viding only very weak evidence for a parent-mediated
effect of CYP2E1*5.
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Reply to Comments by Kraft and Wilson and by
Weinberg and Mitchell on “Parental Genotypes in the
Risk of a Complex Disease”
To the Editor:
Kraft and Wilson (2002 [in this issue]) point out that
there are other analytical options to a joint application
of case-control and TDT analysis in our study of the
effect of parental genetics in the risk of a complex dis-
ease. They propose a “pseudo-sibling controls” design
as an alternative to the approach proposed earlier by
Weinberg and colleagues (1998) to study parental effects
in case-parent trios. However, these tests are directed to
evaluate the effect within a presumed model and are not
designed to estimate joint effects of both parents’ ge-
notypes, which appeared to be the case with our data.
Our study, inspired by original experimental observa-
tions, led us to understand the underlying genetic effects
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that did not follow established paradigms. We concluded
that a number of complementary strategies will need to
be used simultaneously to dissect genetic predisposition
to complex disorders (Labuda et al. 2002). In this regard,
we are in agreement with Kraft and Wilson (2002 [in
this issue]) that additional collecting of control-parent
trios would extend possibilities of testing the observed
effects under a greater variety of genetic and statistical
models.
In the context of simple Mendelian disorders, fig. 1
could be troubling, but our paper was intended to divert
the reader from this paradigm. Indeed, in a highly pen-
etrant autosomal recessive condition, such as cystic fi-
brosis, in which two defective gene copies mean disease,
collecting patients obviously identifies heterozygous par-
ents, who otherwise would be difficult to find in such
numbers in a control population. The example of
Huntington chorea used by Weinberg and Mitchell
(2002 [in this issue]) is rather unfortunate, since, at time
of diagnosis, the case carrier-parent would already suc-
cumb to this disease. In a complex, multifactorial, and
multilocus disease, in which the effect of a given allele
is likely due to gene-gene (i.e., the presence of another
variant at a different locus) and/or gene-environment
interaction (e.g., exposure in only a fraction of carriers),
one does not necessarily expect the enrichment in the
at-risk alleles among patients’ parents, expected in turn
to transmit these alleles “preferentially” to their case-
offspring (fig. 1A). In other words, we believe that figure
1 provides a good illustration of the experimental sit-
uation we faced.
We apologize for not giving satisfactory credit to ear-
lier developments, which was pointed out by Weinberg
and Mitchell (2002 [in this issue]). The fact that refer-
ence to Lande and Price (1989) is also absent among
articles cited by Weinberg et al. (1998) is not an excuse.
Rather, it reflects the fact that these excellent method-
ological contributions were reported in the absence of
experimental data, in contrast, for example, to a recent
paper by Infante-Rivard et al. (2002b) where both the
sampling scenarios include control-parent trios as well
as testing for maternally mediated effects.
Obviously, the mechanisms through which the ma-
ternal and paternal genotypes could influence child phe-
notype might be very different, but their net effect rel-
evant to cancer risk, such as an increased mutation
burden, need not be. In respect to this, different path-
ways controlling the metabolism of carcinogens, the
level of oxidative stress, or the efficiency of DNA repair
may have their unique contributions to the increase in
the level of DNA lesions and, consequently, cancer risk.
The observed effect with CYP2E1*5 is, therefore, not
at all unlikely. It is, however, possible that, for the effect
to occur, the CYP2E1*5 carriers would have to undergo
a particular environmental exposure (Infante-Rivard et
al. 2002a). However, as with all such results, this is the
first report that will have to be confirmed by other stud-
ies that include different populations.
Here, our population of case and control subjects,
both of French-Canadian origin, seems to be excellent
for association studies because of the common genetics
and lifestyle. Moreover, as presented in our report, we
independently tested this population for a possibility of
stratification that, in light of the recent results of Ardlie
et al. (2002), appears to be less of a problem in appro-
priately designed studies. Kraft and Wilson (2002 [in
this issue]) evaluated an underestimation of 11% in the
odds ratio, related to the use of “surrogate” parental
controls. This 11% arises from the elevated disease prob-
ability in the chosen numerical example and actually
corresponds only to 1 SD in the variant frequency
(0.2500.023) estimated in a sample of 350 chromo-
somes. Such extent of variation is expected under ex-
perimental conditions.
Weinberg and Mitchell (2002 [in this issue]) in their
comments were also concerned by the effect of the
CYP2E1*5/*5 homozygotes. Because of the rarity (see
table 1 in Labuda et al. 2002) of the variant in question,
we did not need to consider the effect of its homozygotes.
The dominant effect is, therefore, the one to be assumed
to be consistent with presumed phenotypic outcome of
this allele, leading to higher inducibility and, therefore,
to higher activity of the enzyme (see references in Labuda
et al. 2002).
For the reasons discussed above, we believe that our
study provides solid evidence for the parental effects. It
provides also an experimental illustration of genetic ef-
fects that, although escaping a simple Mendelian para-
digm, were anticipated in earlier studies such as that of
Weinberg and her colleagues (Weinberg et al. 1998).
There is, therefore, no reason to believe that these effects
should not be expected in other complex diseases.
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Partition-Ligation–Expectation-Maximization
Algorithm for Haplotype Inference
with Single-Nucleotide Polymorphisms
To the Editor:
The mapping of SNPs in human genomes has generated
a lot of interest from both the biomedical research com-
munity and industry. In conjunction with SNP mapping,
researchers have shown that haplotypes possess consid-
erably greater potential than the traditional single-SNP
approach in disease-gene mapping and in our understand-
ing of complex landscapes of linkage disequilibrium (LD)
(Goldstein 2001). In silico methods for haplotype recon-
struction have attracted much attention because of their
cost-effectiveness and accuracy (Tishkoff et al. 2000) and
have played an important role in the definition of human
haplotype block structure and in candidate-gene studies
of complex traits (Tabor et al. 2002). In a recent publi-
cation, Niu et al. (2002) proposed a partition-ligation (PL)
strategy and implemented it together with Gibbs sam-
pling, to estimate haplotype phases for a large number of
SNPs. Although the resulting program, HAPLOTYPER,
has been in high demand from many research groups, a
significant portion of researchers are also strongly inter-
ested in using an expectation-maximization (EM)–based
algorithm. In the present letter, we describe how to com-
bine the PL strategy with the EM algorithm and how to
handle the local-mode problem. We also present a fast
and robust method of computing the variance of the es-
timated haplotype frequencies. Some related issues con-
cern the handling of missing data and the multiple im-
putations of haplotype phases.
The EM algorithm is arguably the most popular sta-
tistical algorithm, because of its interpretability and sta-
bility. Compared to the Gibbs sampler, the EM approach
is a deterministic procedure, requires less computing time,
and is easier for convergence check. The output of the
EM algorithm, if not trapped in a local mode, is the max-
imum-likelihood estimate (MLE), which possesses well-
established statistical properties. However, the capability
of most EM-based approaches is restricted to approxi-
mately one dozen loci, because of the memory constraint.
A recently developed program, SNPHAP (see David Clay-
ton’s Web site [SNPHAP: A Program for Estimating Fre-
quencies of Large Haplotypes of SNPs]), is an exception
that, although different from the PL strategy, can handle
many more linked loci by using a progressive-extension
technique.
The essential steps of the PL strategy (Niu et al. 2002)
are as follows: One first breaks down all of the marker
loci into stretches of “atomistic” units and then uses either
the EM algorithm or the Gibbs sampler to construct hap-
lotypes for each unit and to rebuild the phase hierarchi-
cally, through a bottom-up approach. For example, an
individual represented in the lipoprotein lipase (LPL)
gene SNP data set (Nickerson et al. 1998) has the ge-
notype (01200001000000000100010), where 0 stands
for heterozygote and 1 and 2 stand for wild-type and
mutant homozygotes, respectively. Since there are 18 het-
erozygous loci, the standard EM algorithm has to con-
sider 218 possible haplotypes, making it extremely costly
for haplotype estimation. Using the PL strategy, we divide
the linked loci into four “atomistic” units—(012000),
(010000), (000001), and (00010)—and use the EM al-
gorithm to estimate partial haplotypes within each unit.
Afterward, two adjacent partial haplotypes are “ligated”
by using the EM algorithm again, just like phasing two
linked multiallelic markers. The ligation process is re-
peated until the complete phase is determined.
It is well known that the EM algorithm can be trapped
in a local mode. This problem becomes a more serious
issue for the PL-EM strategy, because every atomistic hap-
lotype construction or ligation step involves a complete
EM algorithm implementation. A naive implementation
of the ligation step considers only the partial haplotypes
that have nonzero estimated frequencies in the previous
EM step. However, it appears that one phase configura-
tion (and the corresponding haplotypes with nonzero es-
